Showing results (431-440 of 2,338) with videos related to
Sort By:
Pageof 234
Clinical Lung Cancer|August 9, 2020
Utilization Trends and Factors Associated With ROS1 Testing Among Patients With Advanced Non-small-cell Lung Cancer in US Community PracticesWilliam Wong, Ning Wu, Ravindra Gupta, et al.Clinical Lung Cancer|July 2, 2020
Immune Checkpoint Inhibitors Rechallenge Efficacy in Non-Small-Cell Lung Cancer PatientsElisa Gobbini, Anne Claire Toffart, Maurice Pérol, et al.Clinical Lung Cancer|April 7, 2015
Bevacizumab, Pemetrexed, and Cisplatin, or Bevacizumab and Erlotinib for Patients With Advanced Non-Small-Cell Lung Cancer Stratified by Epidermal Growth Factor Receptor Mutation: Phase II Trial SAKK19/09Oliver Gautschi, Nicholas Mach, Sacha I Rothschild, et al.Clinical Lung Cancer|March 5, 2015
FDG-PET Predicts Pain Response and Local Control in Palliative Radiotherapy With or Without Systemic Treatment in Patients With Bone Metastasis From Non-small-cell Lung CancerFen Zhao, Gang Ding, Wei Huang, et al.Clinical Lung Cancer|March 5, 2015
Risk of Pneumonitis After Stereotactic Body Radiation Therapy in Patients With Previous Anatomic Lung ResectionJason T Hayes, Elizabeth A David, LiHong Qi, et al.Clinical Lung Cancer|June 24, 2014
Fractionated scheme of oral vinorelbine as single-agent therapy or in combination with cisplatin concomitantly with thoracic radiotherapy in stage III non-small-cell lung cancer: dose-escalation phase I trialMaciej Krzakowski, Christel Lucas, Cesare GridelliClinical Lung Cancer|June 24, 2014
Complications from computed tomography-guided core needle biopsy for patients receiving stereotactic body radiation therapy for early-stage lesions of the lungVarun K Chowdhry, Amit K Chowdhry, Nathan Goldman, et al.Clinical Lung Cancer|February 10, 2015
Stereotactic Body Radiotherapy for Synchronous Primary Lung Cancer: Clinical Outcome of 18 CasesTakashi Shintani, Katsuhiro Masago, Kenji Takayama, et al.Clinical Lung Cancer|February 11, 2015
Relationship of Driver Oncogenes to Long-Term Pemetrexed Response in Non--Small-Cell Lung CancerYing Liang, Heather A Wakelee, Joel W NealClinical Lung Cancer|July 3, 2014
The effect of radiotherapy dose on survival in stage III non-small-cell lung cancer patients undergoing definitive chemoradiotherapyMatthew Koshy, Renu Malik, David J Sher, et al.Pageof 234